Position in NTRA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$480,466
+$58,488 QoQ
Shares Held
1,770
-16.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#541
of 846 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PINNACLE ASSOCIATES LTD holds $31,240,530 across 12 Diagnostics & Research names. NTRA ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
21,450 | $10,754,172 | |
| 2 | VCYT |
Veracyte, Inc.
|
106,130 | $6,233,014 | |
| 3 | DHR |
Danaher Corp /De/
|
28,600 | $5,447,728 | |
| 4 | WAT |
Waters Corp /De/
|
9,187 | $3,445,492 | |
| 5 | DGX |
Quest Diagnostics Inc
|
12,733 | $2,698,759 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,089 | $573,293 | |
| 7 | NTRA |
Natera, Inc.
This page
|
1,770 | $480,466 | |
| 8 | ILMN |
Illumina, Inc.
|
2,452 | $431,135 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $480,466 | 1,770 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $421,978 | 2,110 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $484,754 | 2,116 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||